Julphar Bangladesh Oral and Topical Preparations
Annual capacities: 300 million tablets, 150 million capsules, 2 million bottles of dry powder, 2 million tubes of ointments
Julphar Bangladesh started its activities in 2009 as RAK Pharma, and is the only pharmaceutical manufacturing facility in Bangladesh that has received approval from the Ministry of Health, UAE. Julphar Bangladesh conducts its operation with strict compliance to the WHO GMP, the USFDA and the Australian TGA guidelines, sourcing Active Pharmaceuticals Ingredients (APIs) – mainly from certified sources and care for the environment. Excellence is a way of life at Julphar Bangladesh and quality, at the core of its operations, is constantly pushed beyond the limit.